In support of this interpretation, Miat was found to regulate the NGS gene Gria2 in transgenic mouse MB, but MIAT (the human orthologue of Miat) was found not to regulate any NGS genes in these glioma datasets (Supplementary Table S5). The gene discussed is GRIA2; the disease is central nervous system cancer.